pAAVS1-Puro-CAG-mNG2(1-10)
(Plasmid
#206042)
-
PurposeRepair template for the integration of a mNG2(1-10) expression cassette into the AAVS1 locus in human cells.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 206042 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepYTK089
- Backbone size w/o insert (bp) 1874
- Total vector size (bp) 7451
-
Vector typeMammalian Expression, CRISPR, Synthetic Biology ; Donor template
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameAAVS1 homology arms with SA-P2A-Puro marker and CAG-mNG2(1-10) expression cassette
-
Alt nameAAVS1-Puro-CAG-mNG2(1-10)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)5577
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byThe AAVS1 repair template (except for the mNG2(1-10) gene) was obtained from pAAVS1-P-CAG-GFP (Knut Woltjen, Addgene plasmid 80491). The pYTK089 was obtained from John Dueber (Addgene plasmid # 65196).
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.06.28.546942 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAVS1-Puro-CAG-mNG2(1-10) was a gift from Alisa Piekny (Addgene plasmid # 206042 ; http://n2t.net/addgene:206042 ; RRID:Addgene_206042) -
For your References section:
Endogenous tagging using split mNeonGreen in human iPSCs for live imaging studies. Husser MC, Pham NP, Law C, Araujo FRB, Martin VJJ, Piekny A. Elife. 2024 Apr 23;12:RP92819. doi: 10.7554/eLife.92819. 10.7554/eLife.92819 PubMed 38652106